Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Operating Leases (2020 - 2021)

Historic Operating Leases for Alaunos Therapeutics (TCRT) over the last 2 years, with Q3 2021 value amounting to $4.7 million.

  • Alaunos Therapeutics' Operating Leases changed N/A to $4.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2020, which is N/A changed from last year.
  • Alaunos Therapeutics' Operating Leases amounted to $4.7 million in Q3 2021.
  • In the past 5 years, Alaunos Therapeutics' Operating Leases registered a high of $4.9 million during Q2 2021, and its lowest value of $4.0 million during Q4 2020.